Beta Bionics, Inc. is a commercial-stage medical device company. The company is headquartered in Irvine, California and currently employs 420 full-time employees. The company went IPO on 2025-01-30. The firm's product, the iLet Bionic Pancreas (iLet), is an insulin delivery device cleared by the United States Food and Drug Administration (FDA) to utilize adaptive closed-loop algorithms to autonomously determine every insulin dose without requiring a user to count carbohydrate intake. iLet is used for the treatment of Type 1 diabetes (T1D). The firm's solutions include iLet for Adults, iLet for Children, Bionic Circle App and iLet Simulator. The firm is in the early stages of developing an insulin pump that is designed to adhere directly to the skin and administer insulin without the need for tubing, commonly known in the diabetes industry as a patch pump. The company is also in the early stages of developing a bihormonal configuration of the iLet.
Quelle est la performance du prix de l'action BBNX ?
Le prix actuel de BBNX est de $10.52, il a diminué de 3.21% lors de la dernière journée de trading.
Quels sont les thèmes d'affaires principaux ou les industries de Beta Bionics Inc ?
Beta Bionics Inc appartient à l'industrie Health Care et le secteur est Health Care
Quel est la capitalisation boursière de Beta Bionics Inc ?
La capitalisation boursière actuelle de Beta Bionics Inc est de $466.8M
Est-ce que Beta Bionics Inc est un achat, une vente ou un maintien ?
Selon les analystes de Wall Street, 13 analystes ont établi des notations d'analystes pour Beta Bionics Inc, y compris 6 achat fort, 6 achat, 3 maintien, 0 vente et 6 vente forte